Novo Nordisk Sues Eli Lilly Over Weight Loss Ad Claims Pharmaceutical giant Novo Nordisk has filed a lawsuit against US based Eli Lilly, alleging that the latter's advertisements for its weight loss medication, Mounjaro, contain false and misleading claims.
The Danish company asserts that these claims exaggerate the efficacy and safety of Mounjaro, contradicting actual data on the medication.
The lawsuit centers around specific allegations made by Eli Lilly in its advertisements, which Novo Nordisk argues cross the line into outright deception.